These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36251549)

  • 1. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.
    Parker CM; Karchmer AW; Fisher MC; Muhammad KM; Yu PA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S417-S431. PubMed ID: 36251549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of anthrax in pregnant women.
    Meaney-Delman D; Rasmussen SA; Beigi RH; Zotti ME; Hutchings Y; Bower WA; Treadwell TA; Jamieson DJ
    Obstet Gynecol; 2013 Oct; 122(4):885-900. PubMed ID: 24084549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
    Hesse EM; Godfred-Cato S; Bower WA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
    Maxson T; Kongphet-Tran T; Mongkolrattanothai T; Travis T; Hendricks K; Parker C; McLaughlin HP; Bugrysheva J; Ambrosio F; Michel P; Cherney B; Lascols C; Sue D
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S373-S378. PubMed ID: 36251548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
    Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.
    Williams JL; Noviello SS; Griffith KS; Wurtzel H; Hamborsky J; Perz JF; Williams IT; Hadler JL; Swerdlow DL; Ridzon R
    Emerg Infect Dis; 2002 Oct; 8(10):1133-7. PubMed ID: 12396928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.
    Shepard CW; Soriano-Gabarro M; Zell ER; Hayslett J; Lukacs S; Goldstein S; Factor S; Jones J; Ridzon R; Williams I; Rosenstein N;
    Emerg Infect Dis; 2002 Oct; 8(10):1124-32. PubMed ID: 12396927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
    Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA
    MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexposure Prophylaxis After Possible Anthrax Exposure: Adherence and Adverse Events.
    Nolen LD; Traxler RM; Kharod GA; Kache PA; Katharios-Lanwermeyer S; Hendricks KA; Shadomy SV; Bower WA; Meaney-Delman D; Walke HT
    Health Secur; 2016; 14(6):419-423. PubMed ID: 27898235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prophylaxis and treatment of anthrax.
    Brook I
    Int J Antimicrob Agents; 2002 Nov; 20(5):320-5. PubMed ID: 12431866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.
    Martin SW; Tierney BC; Aranas A; Rosenstein NE; Franzke LH; Apicella L; Marano N; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):393-401. PubMed ID: 15717323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.
    Jefferds MD; Laserson K; Fry AM; Roy S; Hayslett J; Grummer-Strawn L; Kettel-Khan L; Schuchat A;
    Emerg Infect Dis; 2002 Oct; 8(10):1138-44. PubMed ID: 12396929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.
    Bower WA; Schiffer J; Atmar RL; Keitel WA; Friedlander AM; Liu L; Yu Y; Stephens DS; Quinn CP; Hendricks K;
    MMWR Recomm Rep; 2019 Dec; 68(4):1-14. PubMed ID: 31834290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
    Hendricks KA; Wright ME; Shadomy SV; Bradley JS; Morrow MG; Pavia AT; Rubinstein E; Holty JE; Messonnier NE; Smith TL; Pesik N; Treadwell TA; Bower WA;
    Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24447897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
    Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D
    Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.